Doctor-led aesthetics in Sutton Coldfield
MDr MaryamAesthetics

Polynucleotides

Polynucleotides for the neck and décolletage: realistic expectations

Polynucleotides may be considered for selected skin-quality concerns on the neck and upper chest, but they cannot lift substantial laxity, remove sun damage or treat every visible line.

5 minute read

Start with the concern, not the treatment name

The neck and décolletage can show fine creasing, dryness, uneven texture, laxity, horizontal lines, pigmentation and visible sun damage. These features do not all have the same cause. Movement, skin quality, underlying support and cumulative ultraviolet exposure can each contribute, so one injectable should not be expected to address them all.

Polynucleotide treatment is generally considered for gradual skin-quality change, such as hydration, texture, elasticity and the appearance of fine lines. It does not provide a surgical lift, replace lost facial volume, erase established neck bands or reliably remove pigmentation and visible blood vessels.

What research has looked at these areas?

A 2026 observational study followed 66 adults treated with one highly purified polynucleotide product over three sessions. The collected questionnaires covered 47 facial treatments, 33 neck treatments and 26 décolletage treatments. Clinicians and patients reported improvement, and no serious adverse events were recorded in the study.

However, there was no untreated or placebo comparison group, the sample for each body area was small and the results related to one formulation and protocol. This means the study cannot show how much change came from treatment rather than expectation, natural variation or assessment methods, nor can it predict the result for every product or patient.

The wider evidence is still limited

A 2025 systematic review found nine aesthetic studies involving 219 participants. It described encouraging findings for wrinkles, texture and elasticity, but rated the evidence low or moderate quality because studies were small and varied in their products, injection areas, techniques and outcome measures.

This is why laboratory explanations about fibroblasts or collagen should not be presented as proof of a visible clinical result. A biological mechanism can support a hypothesis, but patients need evidence about the size, consistency and duration of change in the area actually being treated. Those answers remain incomplete for the neck and décolletage.

Sun-damaged skin needs proper assessment

The upper chest is frequently exposed to ultraviolet light. Polynucleotides do not reverse the DNA damage caused by sun exposure and do not replace daily sun protection. A cosmetic consultation should distinguish ordinary uneven tone from a skin lesion that needs medical assessment rather than injection.

The NHS advises seeking medical review for new rough or scaly patches and for areas that bleed, enlarge, change colour, become tender or develop into a lump. A new or changing mole, persistent sore or unexplained lesion should be assessed before elective treatment. Injecting around it must not delay diagnosis.

A course does not guarantee a lift

A practitioner may recommend more than one session, but the schedule should follow the exact product instructions, area, clinical assessment and response. More sessions or a higher concentration are not automatically better. Products labelled PN or PDRN are not interchangeable, and evidence for one cannot simply be transferred to another.

Progress photographs should use the same lighting, posture, camera distance and neck position. Early swelling can temporarily smooth lines and should not be mistaken for the final outcome. If laxity or muscular bands are the main concern, another approach—or no injectable treatment—may be more appropriate after consultation.

Downtime, adverse effects and suitability

Expected short-term effects include small raised injection points, redness, tenderness, swelling and bruising. Less common problems may include infection, inflammation, persistent lumps or an allergic reaction. Increasing pain, heat, spreading redness, discharge, fever, unusual skin colour or worsening swelling needs prompt clinical advice; urgent symptoms require urgent medical help.

Active infection or inflammation may mean postponing treatment. Pregnancy or breastfeeding, relevant allergies, autoimmune or wound-healing conditions, medicines affecting bleeding and previous injectable reactions require individual discussion. Consultation should cover realistic limitations, alternatives, aftercare and access to review before any neck or décolletage treatment is agreed.

← Back to the journal

Personalised medical assessment

Questions about treatment?

Book a consultation to discuss your concerns, health and treatment options without pressure.

Free consultation – a £1 booking fee secures your appointment